A yearlong phase 3 trial shows elinzanetant can cut hot flashes by nearly three-quarters while maintaining a strong safety profile, positioning it as a promising new option for women seeking alternatives to hormone therapy. Seeking commentary, including: How might this drug help improve care for patients?

Gynecologist: Hot flashes cut by almost 3/4 by new drug elinzanetant

Published on: 9/24/2025

A yearlong phase 3 trial shows elinzanetant can cut hot flashes by nearly three-quarters while maintaining a strong safety profile, positioning it as a promising new option for women seeking alternatives to hormone therapy. Seeking commentary, including: How might this drug help improve care for patients?

Published on: 9/25/2025

Gynecologist: Hot flashes cut by almost three-quarters by new drug elinzanetant

Published on: 9/24/2025

Psychologists or psychotherapists to discuss how smartwatches can improve doctors' wellbeing

Published on: 9/24/2025

Looking for doctors to discuss ways they became resilient

Published on: 9/25/2025

20 Pitching Tips to Win Media Coverage in 2025

Real Pitches That Landed Coverage on WSJ, Forbes & More…

Top 12 AI Tools For Better Media Pitching

How to Pitch a Journo Request? (A Complete Beginner's Guide)